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Abstract 
Raman spectroscopy has become a versatile tool for the in vivo charaterisation of skin. Here we 
describe use of Raman spectroscopy for high resolution optical cross sectioning to resolve skin 
constituents and administered drugs at the cellular level. Percutaneous penetration is typically 
studied using permeation cells with biopsies of animals or human skin. Although this technique 
provides valuable clinical data, little insight is gained in the microstructure of drug penetration 
(intercellular or transcellular) or in the mode of action of applied vehicles or penetration 
enhancers. Therefore, a Raman microspectroscopic method was combined with a confocal 
scanning setup to image the microstructure of commercially available skin models (SkinEthic®) 
and the spatial distribution of penetrated actives. The models’ microstructure was scanned 
without any special treatment or environment such as cutting, staining, freezing, or application of 
vacuum. The non-invasive Raman images reveal the layered structure of stratum corneum. This 
in particular for lipids while water tends to be more evenly distributed. When penetration of the 
hydrophilic active glycerol and the lipophilic octyl methoxycinnamate, OMC, was studied, a strong 
correlation between the local distribution of skin constituents and the hydrophilic / lipophilic 
character of the active was observed. 
 
1 Introduction 
Skin effectively inhibits penetration of chemicals as well as microbial invasion. In particular the 
outer cornified layer of the epidermis, the Stratum corneum (SC), is crucial for the barrier function 
of the skin. A highly ordered structure of hydrated keratin and lipid bilayers with specific variations 
in composition determines the barrier properties, e. g. natural moisturising factors (NMF) hold 
water hygroscopically in skin and an acidic pH on the skin surface protects against microbials
1-4
. 
Thus topically applied drugs have to overcome the SC to penetrate into skin. Their penetration 
properties depend amongst others on their molecular weight and their hydrophilic/lipophilic 
character
5
. In addition, the penetration can be enhanced by vehicles added to the drug’s 
formulation
6-8
. But, accelerated penetration is not in every case desirable. While inflammation 
inhibitors should permeate SC as fast as possible to reach the inflamed area, UV absorbers in 
sun screens should remain at the surface to be effective. Therefore detailed understanding of 
penetration microroute and kinetics is fundamental for developing effective actives and 
formulations. 
In many cases, a direct testing on human skin in vivo is not possible, e.g. because the used 
substances are critical, not yet tested or the methodology is not suitable for in vivo investigations. 
For in vitro studies, biopsies of human or animal skin are used as a substitute with the 
disadvantage that the condition of the ex vivo skin is different to the in vivo situation. In addition, 
access to skin biopsies is limited and the investigators are faced with interbatch variability. 
Therefore reconstructed skin models of human epidermis have been developed in the past 
decades. Skin models commercially available and are widely used for risk assessment and to 
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investigate physiological processes after topical application of an active
9,10
. They are well 
characterized with regards to morphological appearance and lipid composition
11
. These skin 
models are an elegant tool for studying penetration and permeation of topically applied actives 
although the permeability is higher compared to human skin in vitro. But the ranking of 
compounds is similar and the data are highly reproducible
12-14
. The reduced barrier of skin models 
is mainly attributed to differences in lipid composition and lipid lamellar organization as well as the 
lack of desquamation
12,15
. Nevertheless because skin models are readily available and because 
inter-batch variation in composition and structure are controlled, they are a suitable alternative for 
penetration and permeation studies
12,16-18
. 
Many methodologies were applied to study skin penetration and permeation. In vivo methods are 
in general limited by measuring physical properties of the SC barrier such as impedance, water 
content or water loss of the skin rather than directly tracking the active compound
19
. By tape 
stripping, penetration profiles of topically applied actives could be determined, but the active 
concentration is usually averaged per layer and depth
20,21
. The permeation coefficients of topically 
applied actives are mostly determined in vitro using diffusion cells. Both biopsies (human and 
animal skin) and reconstructed skin equivalents were characterized
14,22,23
. These experiments 
provide information on permeation kinetics and quantity as well as on the effect of the 
formulation. In addition, the amount of penetrated actives within the skin layers is quantifiable by 
separating SC, epidermis and dermis. 
We were interested in the skin’s reaction at the early stages of penetration. In addition, the skin 
sample should be in a state as natural as possible. Therefore we applied confocal Raman 
microspectroscopy, a non-invasive and label free method that provides spatially resolved 
information about the chemical composition. Raman spectroscopy is a strong technique for 
analysing biological samples in general
24 
and the penetration, also time and spatially resolved, in 
particular
25-29
. By focussing the excitation laser into the skin sample, penetration of actives is 
tracked in microscale. Furthermore, confocal Raman microspectroscopy allows following changes 
in the molecular composition of the skin during the penetration. This method is even applicable 
for human skin in vivo, e.g. for measuring the water content, depth profiles of skin components or 
topically applied compounds
2,28,30
. Raman spectroscopy was also applied to skin models, but 
without resolving their heterogeneous cellular microstructure
31
. 
Confocal Raman microspectroscopy has the potential in providing information on the 
microstructure of organotypic skin models upon penetration of topically applied actives to deepen 
our understanding in microroute of drug penetration. Because the entire skin sample is 
characterised, the water content can be determined. This is not possible for other imaging 
methods which require special sample treatment or environment such as cutting, staining or 
labelling and freezing or application of vacuum (e.g. immune histology, fluorescence microscopy 
and two-photon imaging) or only sections can be analysed (e.g. energy dispersive X-ray and IR 
spectroscopy)
20,32-37
. 
In this study, we analysed the penetration of topically applied actives into reconstructed human 
epidermis by confocal Raman microspectroscopy. We were interested in the penetration 
microroute at the cellular level together with the chemical composition and structure of the 
epidermal model. Raman based imaging techniques were applied to the skin model and 
distribution maps of skin components and the applied actives were extracted. First, the 
composition and microstructure of untreated skin models was analysed with special focus on 
water and lipid concentration. Then, the penetration of a hydrophilic and a lipophilic active 
(glycerol and octyl methoxy cinnamate, OMC, respectively) was monitored. 
  
2 Materials and Methods 
2.1 Skin models 
Reconstructed human epidermal (RHE) skin substitutes were purchased at SkinEthic® 
Laboratories, Lyon, France. There, keratinocytes are cultured on a polycarbonate filter. The 
epidermis is established by the differentiation of keratinocytes at the air-liquid phase. After 11 
days of growth a functional barrier namely the Stratum corneum is formed. We received the skin 
models at day 18. Three batches of RHE containing 12 RHE models each were investigated and 
various formulations were applied. The RHE models were kept in an incubator for 18 h (37 °C, 5 
% CO2) according to the recommendation of SkinEthic®
10,38
. Afterwards, the RHE models were 
used for the Raman experiments within three days. The typical thickness of the SC at the days of 
experiment was 50 to 60 μm.  
Cryo sections were made to get an overview of the skin structure. They were stained by nile- red 
(lipid staining). As skin model Episkin from SkinEthic® was used. It is constructed on a collagen 
gel and shows a similar SC-epidermis structure to RHE. A stock solution was prepared, which 
contained 0.05 % (wt/vol) Nile red (Sigma) in acetone and was stored at 4 °C. For staining the 
stock solution was diluted with the same volume of a mixture of glycerol / water in a ratio of 75:25 
(vol/vol) to a final concentration of 2.5 mg/ml. A drop of the dye solution was applied to each 
section and immediately covered with a coverslip. Nile red fluorescence was captured with a 
Zeiss microscope equipped with a fluorescein (450 – 490 nm) excitation filter. 
 
2.2 Formulations 
The actives were applied as solutions. Glycerol, octyl methoxycinnamate (OMC) and ethanol 
were purchased at Fluka/Sigma Aldrich. Glycerol and OMC were dissolved in ethanol at room 
temperature; the concentration was 50 wt% and 1 wt%, respectively. This difference in 
concentration is on one hand related to the low solubility of OMC in ethanol and on the other 
hand on the low intensity of the Raman signal of glycerol. But it was expected from literature that 
OMC penetrates slower than glycerol and therefore the chosen concentrations are high enough 
for maintaining reservoir conditions at the skin surface during application
5,39
. 
 
2.3 Topical application 
The skin samples were removed from the incubator 1 h before application. To apply the solutions, 
the skin models were removed from the medium, washed with distilled water and carefully 
dabbed. The solution was applied directly on the surface (20 μl cm
-2
). After 15 min, the 
supernatant solution was removed. The skin models were cut out of the inset and immediately 
placed into a sealed sample holder to avoid drying-out. Raman spectra were acquired right 
thereafter. 
 
2.4 Confocal Raman spectroscopy and spectral fitting 
The Raman spectra were acquired with an alpha 300R Raman microscope (WITec, Ulm, 
Germany) equipped with a 532 nm-excitation laserand a piezo scanning table for three-
dimensional scanning. The sample holder was sealed with a microscope cover glass (Menzel, 
0.13-0.16 mm) and the skin’s surface was in direct contact with the cover glass. Spectra were 
acquired through the cover glass using a 100x/1.25 oil-immersion objective and immersion oil (nD 
= 1.515). Virtual cross sections were obtained by mapping an area of 50 μm in width and up to 50 
μm in depth (0.5 μm step size, 0.2 s integration time per spectrum, spectral range 0 – 4000 cm
-1
, 
spectral resolution 4 cm
-1
). The laser power ( < 30 mW) was adjusted for each measurement. 
Since the skin samples were humid, there were particular difficulties in preventing them from 
thermal degradation. However, thermal degradation happened in some experiments, which were 
then discarded and repeated. We used a fitting procedure based on reference spectra similar to 
Caspers et al.
26
, but we increased the fitting range to 400 to 3800 cm
-1
, which allows the 
simultaneous determination of water OH-stretching vibrations (3300 cm
-1
 to 3700 cm
-1
) and 
fingerprint and functional group peaks from the actives and the skin’s matrix (400 cm
-1
 to 1800 
cm
-1
). 
For each component, a local concentration coefficient ci was obtained by a fitting process. The 
Raman spectrum of a mixture R can be expressed as the sum of component Raman spectra Ri 
multiplied with their concentration coefficients ci: 
 
 
 
If the Raman spectra are represented as vectors, the fitting coefficients can be calculated by a 
matrix division according to: 
 
 
where c is a vector containing all coefficients and A the matrix containing all reference spectra. 
The coefficients ci of an entire optical cross sectioning are then displayed in a distribution map. 
We used the following spectra as references: keratin (as representative of all proteins), lipids 
(average spectrum extracted from RHE model measurements), water, glycerol, OMC and ethanol 
as well as a spectrum from the cover glass. The fitting program was created with the built-in 
software of the Raman instrument. Because the Raman signal in general decreases by focussing 
in a semi-transparent sample, all coefficients are normalized with the Keratin coefficient at the 
same position. It is worth to note that the Keratin content is not homogeneous within epidermis 
but it is the component in the skin which is ubiquitous in considerable concentration
24
. Distribution 
maps were similar between different RHE models, therefore only one example is shown for each 
applied active. 
3 Results and Discussion 
Confocal Raman microspectroscopy was used for high resolution optical cross sectioning of skin 
to resolve skin constituents and topically administered drugs simultaneously and at the cellular 
level.. This means that changes in the skin structure and/or composition can be directly related 
with the penetration behaviour of the penetrating compound. 
3.1 Untreated samples 
Before the penetration of any active was analysed, untreated RHE samples were studied. A 
Raman spectrum close to the surface is given in Fig. 1. Virtual cross sections were made of the 
SC of skin models by imaging with confocal Raman microspectroscopy. The distribution map of a 
particular component is constructed by displaying the fitting coefficients of the corresponding 
reference relative to the position of moving microscope stage. In this way, a distribution map for 
each reference was extracted, that corresponds to the relative concentration of the compound of 
interest. Water and lipid distribution of the untreated skin model are shown in Fig. 2. The lipid 
distribution is resolved at the cellular level and a fine structure corresponding to the layered 
structure of the skin model is observed: we find thin lipid layers and micron-sized lipid droplets 
(see Fig. 2 middle). The layers are mainly parallel to the skin surface and occasionally, they show 
kinks. The lipid stained biopsy shows the same structural features (see Fig. 2 right). Water has a 
complimentary distribution to lipids, i.e. a low local water concentration is observed at spots with 
high lipid concentration and vice versa. 
There are important differences between the here investigated RHE models and the human in 
vivo situation. First, the thickness of the SC is different and with 50 to 60 μm thickness in RHE 
significantly larger than typical values for the human volar forearm with 10 to 20 μm. This, 
because the SC is growing continuously in RHE models due to the lack of desquamation. 
Second, the water content in RHE models is higher than in the human in vivo situation 
(approximately 70 wt% compared to typically 25 – 35 wt%). The higher water content is possibly 
a result of the high humidity conditions given during the incubator cultivation. A water gradient 
similar to the human skin in vivo is not observed for skin models
27
. Third, the ceramide content is 
higher in the SC of human skin compared to the epidermal layers, while for RHE, the ceramide 
content fluctuates around a high value. Forth, we did not observe any natural moisturizing factors 
(NMF) within the RHE models by Raman spectroscopy, while NMF molecules are detectable by 
Raman spectroscopy for human skin in vivo
2
. These differences may explain the different barrier 
properties of skin models and human skin, which have already been outlined in several 
investigations
14,40
. 
 
3.2 Glycerol, a hydrophilic active 
As hydrophilic active, glycerol, a skin moisturizer, was analysed (water-octanol partition 
coefficient log KOW = -1.76)
11
. The peaks of glycerol appear in the Raman spectrum of treated RHE 
models (see Fig. 1). The distribution maps of glycerol, lipids and water show that glycerol 
concentration is high in the water-rich areas and low in the lipid-rich areas (see Fig. 3). This is 
expected for a hydrophilic species. Glycerol led to a swelling of the water-rich domains. Thus the 
lipid layers are more separated than in the untreated skin model. 
 
3.3 Octyl methoxycinnamate (OMC), a lipophilic active 
As hydrophobic active, we chose octyl methoxycinnamate (OMC) which is a UV absorber that is 
found in many sun screen formulations (water-octanol partition coefficient log KOW = +6.1). The 
peaks of OMC appear in the Raman spectrum of treated skin (see Fig. 1). Even at low 
concentration, the Raman spectrum is dominated by the OMC due to its high Raman activity. The 
distribution maps show that OMC is accumulated at the skin’s surface and has only penetrated a 
short distance into the SC within the 15 min of application (see Fig. 4). The local concentration of 
OMC varies within equal depth. The areas of highest concentration correspond to lipid droplets in 
the lipid distribution map (see marks in Fig. 4), i.e. OMC is concentrated in the lipid-rich area. 
The coefficients of the actives correlate with the water coefficients (see Fig. 5). For OMC treated 
RHE models, the OMC coefficients show a negative correlation with the water coefficients. That 
affirms the conclusions drawn from the distribution maps, mainly preference of OMC for the lipid 
phase rather than the aqueous phase. In contrast, the glycerol coefficients correlate positively 
with the water coefficients for glycerol treated RHE models, as expected from the hydrophilic 
character of glycerol. 
4 Conclusion 
We developed a Raman based method to visualize the distribution of lipids, water, and topically 
applied actives in reconstructed human epidermal models. By applying this confocal Raman 
microspectroscopic approach, we analysed the penetration of a hydrophilic and a lipophilic active 
into the RHE models. In untreated RHE models the water content is high throughout the entire 
SC. Typical water gradients as for human skin in vivo, starting with a low water content at the 
SCs surface that increases down to the epidermis, are not observed for the RHE models. In 
addition to the lipid layers that are also observed in SC, lipid droplets appeared. NMF is missing. 
After topical application of actives to RHE models, their distribution was characterized. The 
distribution maps reveal higher glycerol concentration in water-rich domains while OMC was 
concentrated in the lipid droplets. 
The results show in how far the local constitution of skin triggers the local distribution of topically 
administered actives. The demonstrated Raman methodology can be used to understand 
penetration microroutes and to improve current skin models – in particular with respect to their 
barrier properties that should mimic the in vivo situation of human skin. 
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6 Figure legends 
Fig. 1: Raman spectra of skin models close to the surface: untreated skin and skin treated with 
glycerol and OMC, respectively; compared to the Raman spectra of the pure compounds 
(averaged spectra). Some of the characteristic peaks of the pure actives are marked by arrows in 
the Raman spectra of treated skin. 
Fig. 2: Virtual cross section of a skin model obtained by confocal Raman microspectroscopy: 
Distribution of water and lipids (left and middle). Histologic sections stained nile red for lipids 
(right). The typical thickness of the SC was 50 to 60 μm. Relative concentrations: bright color 
corresponds to high concentration, dark color to low concentration. 
Fig. 3: Virtual cross section of a skin model obtained by confocal Raman microspectroscopy: 
Distribution of water, lipids and glycerol extracted from Raman measurements (measured from 
skin surface to depth through entire skin model). Relative concentrations: bright color 
corresponds to high concentration, dark color to low concentration. 
Fig. 4: Virtual cross section of a skin model obtained by confocal Raman 
microspectroscopyscopy: Distribution of water, lipids and OMC extracted from Raman 
measurements (measured from skin surface to depth through entire skin model). Relative 
concentrations: bright color corresponds to high concentration, dark color to low concentration. 
Triangular marks indicate areas with high relative OMC and lipid concentration while the water 
concentration is low. 
Fig. 5: Correlation of the fit coefficients for glycerol (left) and OMC (right) with the water 
coefficients in treated RHE models. 
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